Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients

International Journal of Medical Microbiology : IJMM
Hans-Walter Pfister, Tobias A Rupprecht

Abstract

The diagnostic criteria of active neuroborreliosis include inflammatory changes of the cerebrospinal fluid (CSF) and an elevated specific Borrelia CSF-to-serum antibody index, indicating intrathecal Borrelia antibody production. Patients with neuroborreliosis are usually treated with intravenous ceftriaxone for 2-3 weeks. In case of allergy, doxycycline may be used. Treatment efficacy is detected by the improvement of the neurological symptoms and the normalization of the CSF pleocytosis. The measurement of serum and CSF antibodies is not suitable for follow-up, because they frequently persist. Post-Lyme disease (PLD) syndrome is characterized by persistent complaints and symptoms after previous treatment for Lyme borreliosis, e.g., musculoskeletal or radicular pain, dysaesthesia, and neurocognitive symptoms that are often associated with fatigue. There is no formal definition of the PLD syndrome, and its pathogenesis is unclear. Recent controlled studies do not support the use of additional antibiotics in these patients, but recommend primarily symptomatic strategies.

References

May 1, 1975·Journal of Neurology, Neurosurgery, and Psychiatry·H C Hopf
Aug 1, 1990·Brain : a Journal of Neurology·J HalperinR J Dattwyler
Nov 22, 1990·The New England Journal of Medicine·E L LogigianA C Steere
Aug 1, 1990·Stroke; a Journal of Cerebral Circulation·E F May, B Jabbari
Nov 1, 1989·Klinische Pädiatrie·W GörkeC Severien
Jul 1, 1989·Antimicrobial Agents and Chemotherapy·L Dotevall, L Hagberg
May 1, 1993·Journal of Neurology·C D ReimersP H Duray
Jun 1, 1996·Annals of Medicine·H J Christen
Mar 7, 1998·Annals of Internal Medicine·M C ReidR I Horwitz
Feb 9, 2000·JAMA : the Journal of the American Medical Association·E G SeltzerE D Shapiro
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R PatelN M Schwenk
Jan 3, 2001·The Journal of Infectious Diseases·R A KalishA C Steere
Jan 22, 2004·Vector Borne and Zoonotic Diseases·Bettina Wilske
Apr 16, 2004·The Journal of Clinical Investigation·Allen C SteereLisa Glickstein

❮ Previous
Next ❯

Citations

Sep 8, 2011·Journal of Neurology·Marija DjukicHolger Schmidt
Aug 9, 2008·Der Schmerz·T A RupprechtH-W Pfister
Sep 4, 2009·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Monica M Mariani, Tammy Kielian
Mar 8, 2008·Epidemiology and Infection·J K LovettN J Gutowski
Dec 20, 2013·Journal of Child and Adolescent Psychopharmacology·Presenters Mehmet C TosyaliDiscussant Barbara J Coffey
Nov 26, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A MyglandUNKNOWN European Federation of Neurological Societies
Feb 9, 2010·BMC Infectious Diseases·Ivar TjernbergPia Forsberg
Aug 17, 2010·Revue D'épidémiologie Et De Santé Publique·D Gueorguiev PenevE Rusch
May 19, 2009·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·A Pérez LópezB Beinbrech
Jun 18, 2008·Acta Neurologica Scandinavica. Supplementum·U Ljøstad, T-H Henriksen
Feb 16, 2011·Acta Neurologica Scandinavica·N WutteE Aberer
Feb 10, 2011·Acta Neurologica Scandinavica·R EikelandU Ljøstad
Dec 5, 2012·Acta Neurologica Scandinavica. Supplementum·U Ljøstad, Å Mygland
Jul 29, 2015·Nature Reviews. Neurology·Uwe KoedelHans-Walter Pfister
Dec 6, 2016·International Journal of Environmental Research and Public Health·Lilija KovalchukaAngelika Krumina
Apr 1, 2018·BMJ Case Reports·Marta EzequielCatarina Luís
Feb 22, 2008·Muscle & Nerve·Tobias A RupprechtHans-Walter Pfister
Dec 22, 2007·Molecular Medicine·Tobias A RupprechtHans-Walter Pfister
Mar 9, 2020·Neuromodulation : Journal of the International Neuromodulation Society·Jay Karri, Brian Bruel
Jun 28, 2008·Scandinavian Journal of Infectious Diseases·Anna BaehrReinhard Berner
Nov 10, 2007·Onkologie·Carmen D SchweighoferMarcel Reiser
Dec 21, 2013·International Journal of Immunopathology and Pharmacology·A AmedeiM M D' Elios
Aug 5, 2019·Revue neurologique·G Summer, T A Rupprecht

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.